key: cord-0748193-webr0m2n
authors: He, Steven; Hecimovic, Anthony; Matijasevic, Vesna; Mai, Ha Thi; Heslop, Linda; Foster, Jann; Alexander, Kate E.; Pal, Naru; Alexandrou, Evan; Davidson, Patricia M.; Frost, Steven A.
title: Prevalence of SARS‐CoV‐2 antibodies among nurses: A systematic review and meta‐analysis
date: 2021-09-27
journal: J Clin Nurs
DOI: 10.1111/jocn.16009
sha: 7e9ddb73882c4bbd5288488f1dbe1d7638bb8df5
doc_id: 748193
cord_uid: webr0m2n

AIMS AND OBJECTIVES: This systematic review and meta‐analysis reports the seroprevalence of SARS‐CoV‐2 antibodies among nurses. BACKGROUND: With a growing body of literature reporting the positive serology for SARS‐CoV‐2 antibodies among healthcare workers, it remains unclear whether staff at the point of direct patient care are more prone to developing and transmitting the virus. Given nurses make up the majority of the global health workforce, outbreaks among these workers could severely undermine a health system’s capability to manage the pandemic. We aimed to summarise and report the seroprevalence of SARS‐CoV‐2 antibodies among nurses globally. DESIGN: Systematic review and meta‐analyses. METHODS: This systematic review was developed, undertaken and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guideline. We searched the electronic medical literature databases: MEDLINE; CINAHL; and EMBASE for studies reporting the seroprevalence of SARS‐CoV‐2 antibodies among nursing staff. Studies that reported nursing specific data were included in this review. Study quality was evaluated using the Joanna Briggs Institute checklist for studies reporting prevalence data. Studies were stratified according to the World Health Organisation region classifications, and results were presented using forest plots and summary prevalence and variance was estimated using a random effects model. RESULTS: Our electronic search identified 1687 potential studies, of which 1148 were screened for eligibility after duplicates were removed, and 51 of the studies were included in our meta‐analysis. The overall seroprevalence of SARS‐CoV‐2 antibodies among nurses was estimated to be 8.1% (95% CI 6.9%–9.4%) among the 60,571 participants included in the studies. Seropositivity was highest in the African region (48.2%, 95% CI 39.2%–57.3%), followed by the European region (10.3%, 95% CI 8.0%–12.5%), the Region of the Americas (8.4%, 95% CI 6.0%–10.7%), the South‐East Asia region (3.0%, 95% CI 0.00%–6.5%) and the Western Pacific region (0.5%, 95% CI 0.0%–1.0%). Pooled estimates were unable to be calculated in the Eastern Mediterranean region due to insufficient studies. CONCLUSION: The seroprevalence of SARS‐CoV‐2 antibodies among nurses is comparable to other healthcare workers, and possibly similar to the general population. Early adoption and adherence to personal protective equipment and social distancing measures could explain these similarities, meaning the majority of staff contracted the virus through community transmission and not in a healthcare setting. RELEVANCE TO CLINICAL PRACTICE: Fear and uncertainty have been features of this pandemic, including among nurses. This meta‐analysis should provide some comfort to nurses that risks are similar to community exposure when adequate PPE is available and there is an adherence to infection control measures.

The coronavirus disease 2019 (COVID-19) is a respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first encountered in December 2019 and continues to challenge governments and healthcare systems across the globe. As of 19 April 2021, the World Health Organization [WHO] (2021) has reported over 141 million cases and over three million attributable deaths since the beginning of the pandemic, with hundreds of thousands of cases detected each day. Serological surveys have also been conducted to help determine the underlying prevalence of SARS-Cov-2 and provide some insight on transmission between asymptomatic individuals. A 2021 systematic review found a seroprevalence rate of 8.0% among the global population (Chen et al., 2021) .

Infection rates among healthcare workers are of particular concern, given they seem to be at high risk of both developing and transmitting the illness Pan et al., 2020; Quigley et al., 2021; Schneider et al., 2020; Wu & McGoogan, 2020) . It remains unclear whether staff at the point of direct patient care are more prone to developing and transmitting the virus, due to limited available data around community transmission (Hunter, Price, et al., 2020; Misra-Hebert et al., 2020) . A recent systematic review, however, reported nurses accounted for half of all SARS-CoV-2 positive serology among healthcare workers, suggesting prolonged exposure to direct patient care may be a contributing factor (Gómez-Ochoa et al., 2020) . Given nurses make up the majority of the global health workforce, outbreaks among these workers could severely undermine a health system's capabilities to manage the pandemic, particularly in low resource settings (WHO, 2020). Specific rates among nursing staff have not been summarised and reported, and further research is needed to determine whether nurses are at higher risk of infection than other members of the healthcare team. Therefore, this systematic review and meta-analysis were planned to summarise and report the seroprevalence of SARS-CoV-2 antibodies among nurses globally. personnel, health worker, health workforce, health professional, nurse, sero-epidemiologic studies, seroprevalence, antibodies, serologic tests, immunoglobulin, IgG, IgA and IgM. Preprint studies and results prior to 2019 were excluded. We also searched Google Scholar for primary citations and checked any subsequent citation of papers included in our review. A hand search of the references lists of all included papers was also undertaken to ensure no further papers could be included in our systematic review and meta-analysis.

All observational studies were considered, and longitudinal studies were only included if a point prevalence was reported (baseline figures were extracted). Studies must have assessed the prevalence of SARS-CoV-2 using a serological test that detected the presence of SARS-CoV-2 antibodies (IgG, IgM, IgA or a combination of the three) among a sample of healthcare workers. Studies that did not report any raw nursing data were excluded.

We merged all the retrieved studies from individual databases into Endnote version X9.3.3 and all duplicate references were filtered and removed. Authors SH and HM independently reviewed selected titles and abstracts for potential inclusion. If any discrepancies were observed between the review authors and could not be resolved, review authors SF and EA would be consulted to arbitrate (this was not required). We also scanned the reference lists and citations of included studies for further references to additional studies. Study authors were contacted for additional information when nursing and/or serological specific data was not made clear due to grouping with other measures of outcomes.

Extraction of data was conducted by one investigator (SH) and was validated by another (SF). Information acquired included: first author;

year of publication; study design; dates of data collection; region/ country of study; sample size; therapeutic areas assessed; number of sites where the study was conducted; antibodies assessed; and type of immunoassay. With regard to studies that utilised multiple immunoassays, the final immunoassay used to determine seropositivity was recorded.

Quality assessment of the studies was undertaken by the two authors (SH and HM) using the Joanna Briggs Institute (JBI) critical appraisal checklist for studies reporting prevalence data (Munn et al., 2015) . Despite there being a lack of consensus around how to appraise prevalence studies, the JBI checklist has been found to be the most comprehensive and widely used amongst researchers (Borges Migliavaca et al., 2020) . A scaling measurement was created to differentiate studies according to a level of quality. One point was assigned to each 'Yes' response to the nine checklist items (Low = 0-4 checklist items; Moderate = 5-7 checklist items; High = 8-9 checklist items). No studies were excluded on the basis of quality.

The seroprevalence rates of SARS-CoV-2 antibodies among nurses were expressed as proportions with 95% confidence intervals and presented as Forest plots (Barendregt et al., 2013) . We considered the degree of heterogeneity of results by calculating the I 2 statistic. In order to minimise heterogeneity between seroprevalence estimates, the studies were stratified and data pooled according to WHO region classifications: African region, Eastern Mediterranean region, European region, Region of the Americas, South-East Asia region and Western Pacific Region. A random effects (RE) model was used to present pooled seroprevalence estimates due to high heterogeneity post-stratification. Publication bias was assessed upon visual inspection of forest plot and test of plot asymmetry (Egger et al., 1997) . All analysis was undertaken using the meta-package as part of the R statistical program (R Core Team, 2017).

Our initial search generated 1687 results, from which 539 duplicates were removed. The remaining 1148 studies had their titles and abstracts screened for compliance with our eligibility criteria (see Figure 1 PRISMA search flowchart). Fifty-one studies were included in the final review (see Table 1 for study characteristics), with the majority of the studies conducted in the Region of the Americas region (n = 19), followed by the European region (n = 18), Western Pacific region (n = 8), South-East Asia region (n = 3), African region (n = 2) and Eastern Mediterranean (n = 1).

Utilising the JBI critical appraisal checklist, we determined 16 studies to be of high quality, 33 studies to be of moderate quality and two studies were considered low quality. The majority of investigations recruited participants appropriately, either by inviting the entire target population or randomly selecting their sample (n = 38, 75%). Twentytwo studies did not report a response rate, and forty-four studies did not provide evidence of sufficient coverage of the identified sample.

The overall seroprevalence of SARS-CoV-2 antibodies among nurses was estimated (using random effects modelling) to be 8.1% (95% CI 6.9%-9.4%) among the 60,571 participants included in all the studies (see Figure 2 for forest plot). Pooled seroprevalence estimates varied across WHO regions, with the highest rates observed in the African region (48.2%, 95% CI 39.2%-57.3%), followed by the European region (10.3%, 95% CI 8.0%-12.5%), the Region of the Americas (8.4%, 95% CI 6.0%-10.7%), the South-East Asia region (3.0%, 95% CI 0.00%-6.5%) and the lowest rates in the Western Pacific region (0.5%, 95% CI 0.0%-1.0%). Overall statistical heterogeneity was obvious from the forest plots and supported by the high I 2 statistic (99%). Pooled estimates were unable to be calculated in the Eastern Mediterranean region due to insufficient studies (n = 1).

Only two regions (European region and the Region of the Americas) met the minimum number of studies (n > 10) required for testing of funnel plot asymmetry. Funnel plots and associated p values from Egger's test are presented in the Appendices 1 and 2.

Our study found that the pooled seroprevalence of SARS-CoV-2 antibodies among nurses was 8.1%, ranging from 0% to 51% between studies. Within the growing body of literature investigating the prevalence of SARS-COV-2 among healthcare workers, it is important to determine whether certain occupations experience higher rates of infection. A recent systematic review reported that nurses accounted for almost half of their positive cases, suggesting it could be attributed to their prolonged exposure to patients when delivering care (Gómez-Ochoa et al., 2020).

Our results are congruent with rates reported in healthcare workers as a whole, with 7% and 8.7% in reviews conducted by Gómez-Ochoa et al. (2020) and Galanis et al. (2021) , respectively. These findings seem to suggest that despite differences in roles, the likelihood of infection for nurses is similar to other healthcare workers.

Given nurses make up around 50% of the health workforce, the high proportion of SARS-CoV-2 positive nurses seen in previous studies may simply be due to overrepresentation (Bandyopadhyay et Heterogeneity: Tau 2 = 0.0025; Chi 2 = 1720.13, df = 18 (P = 0); I 2 = 99% Heterogeneity: Tau 2 = 0.0009; Chi 2 = 23.42, df = 2 (P < 0.01); I 2 = 91%

Heterogeneity: Tau 2 = < 0.0001; Chi 2 = 18.48, df = 7 (P < 0.01); I 2 = 62%

Mukwege (2021) Olayanju (2021) Kassem (2020) Amendola (2020) Barallat (2020) Finkzeller (2020) Galan (2020) Garcia−Basteiro (2020) Isherwood (2020) Iversen (2020) Kohler (2020) Olalla (2020) Perez Garcia (2020) Plebani (2020) Rudberg (2020) Schmidt (2020) Steensels (2020) Brehm (2021) Calcagno (2021) El Bouzidi (2021) Garralda Fernandez

Akinbami (2020) Barrett (2020) Costa (2020) Dimcheff (2020) Godbout (2020) Hunter (2020) Jeremias (2020) Moscola (2020) Nicholson (2020) Rosser (2020) Self (2020) Stubblefield (2020) Yogo (2020) Akinbami (2021) Gandhi (2021) Howard−Anderson (2021) Murakami (2021) Purswani (2021) Venugopal (2021) Kumar (2020a) Kumar (2020b) Khan (2021) Chau ( between professions could also be a result of mandated personal protective equipment (PPE) use and compliance with social distancing measures, both of which have been shown to reduce the risk of COVID-19 infection in healthcare workers (Feng et al., 2020; Lewnard & Lo, 2020; Nguyen et al., 2020) . Instead, any variance in this population may be due to the clinical specialty the workers operate in, that may influence the level of occupational exposure to COVID-19 patients. Our study lacked the data to compare seroprevalence among different specialty areas. However, a recent systematic review by Chen et al. (2021) found that high-risk healthcare workers experienced significantly higher seroprevalence than lowrisk healthcare workers. It is important to note there are potential confounding variables influencing these results, as the authors categorised high-risk healthcare workers as personnel in contact with COVID-19 patients and those with inadequate access to PPE.

We found seropositivity varied among countries, with those in (Allegranzi et al., 2011; Harrison et al., 2015) . Potential contributing factors could include poor health infrastructure, inadequate access to resources and limited application of infection control measures (Allegranzi et al., 2011; Ogunsola & Mehtar, 2020) . Be that as it may, a recent publication suggested the preparedness of African countries to manage COVID-19 was underestimated, when one considers recent work undertaken with the Ebola outbreak of the mid-2010s (Kapata et al., 2020) . Kapata et al. (2020) also highlighted that early recognition of the risk of COVID-19, and assistance from WHO had may somewhat mitigate African nations to widespread and potentially uncontrollable disease. It is difficult to assess whether such preparations have had an effect on seroprevalence among African countries, given the lack of studies and reported data within this region.

To the authors' knowledge, this is the first systematic review that specifically investigates the seroprevalence of SARS-CoV-2 among nurses. A potential limitation to this meta-analysis, as with any 

To conclude, the overall seroprevalence of SARS-CoV-2 antibodies in nurses is comparable to other healthcare workers, and possibly the general population depending on the setting. Early adoption and adherence to PPE and social distancing measures could explain these similarities, meaning the majority of staff could be contracting the virus through community transmission and not in a healthcare setting. More research is needed to investigate whether this observation is valid, given the mixed evidence currently available.

The COVID-19 pandemic has identified a range of vulnerabilities across society and also in healthcare settings. The availability and access to PPE and training in infection control practices have been major factors in protecting healthcare workers . Workforce shortages and limited PPE have demonstrated the vulnerability of the aged care sector and reflected in high mortality (Davidson & Szanton, 2020) . Fear and uncertainty have also been features of the pandemic including among nurses . This meta-analysis should provide some comfort to nurses that risks are similar to community exposure when adequate PPE is available and there is adherence to infection control measures.

The global pandemic has challenged traditional models of occupational health and safety as well as challenging standards of reporting and monitoring. Standardising methods of monitoring occupational exposure are important in ensuring protection for health workers . Given the evolution of SARS-CoV-2 virus and vaccination strategies, ongoing monitoring and assessment of seroprevalence are necessary.

The authors declare no conflicts of interest. 

Severe acute respiratory syndrome coronavirus 2 seropositivity among healthcare personnel in hospitals and nursing homes

SARS-CoV-2 seroprevalence among healthcare, first response, and public safety personnel

Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis

Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave

Infection and mortality of healthcare workers worldwide from COVID-19: A systematic review

Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave

Risk factors for severe acute respiratory syndrome coronavirus 2 infection in hospital workers: Results from a screening study in New Jersey, United States in spring 2020

How are systematic reviews of prevalence conducted? A methodological study

Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study

Risk for SARS-CoV-2 infection in healthcare workers

Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam

Serological evidence of human infection with SARS-CoV-2: A systematic review and meta-analysis. The Lancet Global Health

High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence and risk factors among oligo/asymptomatic healthcare workers: Estimating the impact of community transmission

Moral outrage in COVID19-Understandable but not a strategy

Nursing homes and COVID-19: We can and should do better

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection among VA healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside of the work environment

Bias in metaanalysis detected by a simple, graphical test

Severe acute respiratory syndrome coronavirus-2 infections in critical care staff: Beware the risks beyond the bedside

Rational use of face masks in the COVID-19 pandemic. The Lancet Respiratory Medicine

SARS-CoV-2 antibodies in ICU and clinic staff: From Germany's region with the highest infection rate

Aus der am hochsten durchseuchten Region Deutschlands

Quantitative SARS-CoV-2 antibody screening of healthcare workers in the southern part of Kyoto City during the COVID-19 pre-pandemic period

Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital

Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: A systematic review and meta-analysis

COVID-19 serologic testing among the highest risk healthcare workers

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare workers in a low prevalence region

COVID-19 in health-care workers: A living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes

Patient safety and quality of care in developing countries in Southeast Asia: A systematic literature review

SARS-CoV-2 IgG seroprevalence among medical staff in a general hospital that treated patients with COVID-19 in Japan: Retrospective evaluation of nosocomial infection control

Occupational risk factors for SARS-CoV-2 infection among healthcare personnel: A crosssectional analysis of subjects enrolled in the COPE study

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure

First experience of COVID-19 screening of health-care workers in England

Prevalence of SARS-COVID-19 serum IgG antibodies amongst staff on an acute surgical unit

Risk of COVID-19 in health-care workers in Denmark: An observational cohort study. The Lancet Infectious Diseases

Vulnerability of nurse and physicians with COVID-19: Monitoring and surveillance needed

Prevalence of SARS-CoV-2 infection among health care workers in a tertiary community hospital

Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future

SARS-CoV-2 infection among healthcare workers of a gastroenterological service in a tertiary care facility

SARS-CoV-2 seroprevalence among healthcare workers by workplace exposure risk in Kashmir

Serologic evaluation of healthcare workers caring for COVID-19 patients in the Republic of Korea

Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study

SARS-CoV-2 antibodies in healthcare workers in a large university hospital

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in Mumbai, India

Scientific and ethical basis for social-distancing interventions against COVID-19

Survey of the current status of subclinical coronavirus disease 2019 (COVID-19)

Impact of the COVID-19 pandemic on healthcare workers' risk of infection and outcomes in a large, integrated health system

Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City Area

High SARS-CoV-2 seroprevalence in healthcare workers in

Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data

COVID-19 infection among emergency department healthcare providers in a large tertiary academic medical center following the peak of the pandemic

Risk of COVID-19 among front-line health-care workers and the general community: A prospective cohort study

Healthcare worker seroconversion for SARS-CoV-2 at two large health systems

Challenges regarding the control of environmental sources of contamination in healthcare settings in low-and middle-income countries -A narrative review

Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: A Spanish experience

SARS-CoV-2 seropositivity in asymptomatic frontline health workers in Ibadan

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan

SARS-CoV-2 infection among hospital workers of one of the most severely affected institutions in Madrid, Spain: A surveillance cross-sectional study

SARS-CoV-2 serosurvey in health care workers of the Veneto Region

SARS-CoV-2 seroprevalence among healthcare workers by job function and work location in a New York Inner-City Hospital

Estimating the burden of COVID-19 on the Australian healthcare workers and health system during the first six months of the pandemic

R: A language and environment for statistical computing

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff

SARS-Coronavirus-2 cases in healthcare workers may not regularly originate from patient care: Lessons from a university hospital on the underestimated risk of healthcare worker to healthcare worker transmission

Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network -13 academic medical centers

Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium

Seroprevalence of SARS-CoV-2 among frontline healthcare personnel during the first month of caring for patients with COVID-19

Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo

Surveillance of SARS-CoV-2 infection among frontline health care workers in Wuhan during COVID-19 outbreak

SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic

Weekly operational update on COVID-19 -19

Nursing and midwifery

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Point prevalence survey to evaluate the seropositivity for coronavirus disease 2019 (COVID-19) among high-risk healthcare workers